Wall Street Analysts Predict a 74.25% Upside in AngioDynamics (ANGO): Here's What You Should Know

Core Viewpoint - AngioDynamics (ANGO) shares have increased by 26.5% in the past four weeks, closing at $7.65, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $13.33, representing a 74.3% upside [1] Price Targets and Analyst Consensus - The average price target for ANGO ranges from a low of $13 to a high of $14, with a standard deviation of $0.58, indicating a strong agreement among analysts about the stock's potential price movement [1][4] - The lowest estimate suggests a 69.9% increase from the current price, while the highest estimate points to an 83% upside [1] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism regarding ANGO's earnings prospects, as evidenced by a 30.2% increase in the Zacks Consensus Estimate for the current year, with two estimates moving higher and no negative revisions [5] - ANGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [5] Caution on Price Targets - While price targets are a popular metric, relying solely on them for investment decisions may not be prudent due to historical inaccuracies in predicting stock price movements [2][3][4] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated estimates [3]